Tag Archives: tests
#435621 ANYbotics Introduces Sleek New ANYmal C ...
Quadrupedal robots are making significant advances lately, and just in the past few months we’ve seen Boston Dynamics’ Spot hauling a truck, IIT’s HyQReal pulling a plane, MIT’s MiniCheetah doing backflips, Unitree Robotics’ Laikago towing a van, and Ghost Robotics’ Vision 60 exploring a mine. Robot makers are betting that their four-legged machines will prove useful in a variety of applications in construction, security, delivery, and even at home.
ANYbotics has been working on such applications for years, testing out their ANYmal robot in places where humans typically don’t want to go (like offshore platforms) as well as places where humans really don’t want to go (like sewers), and they have a better idea than most companies what can make quadruped robots successful.
This week, ANYbotics is announcing a completely new quadruped platform, ANYmal C, a major upgrade from the really quite research-y ANYmal B. The new quadruped has been optimized for ruggedness and reliability in industrial environments, with a streamlined body painted a color that lets you know it means business.
ANYmal C’s physical specs are pretty impressive for a production quadruped. It can move at 1 meter per second, manage 20-degree slopes and 45-degree stairs, cross 25-centimeter gaps, and squeeze through passages just 60 centimeters wide. It’s packed with cameras and 3D sensors, including a lidar for 3D mapping and simultaneous localization and mapping (SLAM). All these sensors (along with the vast volume of gait research that’s been done with ANYmal) make this one of the most reliably autonomous quadrupeds out there, with real-time motion planning and obstacle avoidance.
Image: ANYbotics
ANYmal can autonomously attach itself to a cone-shaped docking station to recharge.
ANYmal C is also one of the ruggedest legged robots in existence. The 50-kilogram robot is IP67 rated, meaning that it’s completely impervious to dust and can withstand being submerged in a meter of water for an hour. If it’s submerged for longer than that, you’re absolutely doing something wrong. The robot will run for over 2 hours on battery power, and if that’s not enough endurance, don’t worry, because ANYmal can autonomously impale itself on a weird cone-shaped docking station to recharge.
Photo: ANYbotics
ANYmal C’s sensor payload includes cameras and a lidar for 3D mapping and SLAM.
As far as what ANYmal C is designed to actually do, it’s mostly remote inspection tasks where you need to move around through a relatively complex environment, but where for whatever reason you’d be better off not sending a human. ANYmal C has a sensor payload that gives it lots of visual options, like thermal imaging, and with the ability to handle a 10-kilogram payload, the robot can be adapted to many different environments.
Over the next few months, we’re hoping to see more examples of ANYmal C being deployed to do useful stuff in real-world environments, but for now, we do have a bit more detail from ANYbotics CTO Christian Gehring.
IEEE Spectrum: Can you tell us about the development process for ANYmal C?
Christian Gehring: We tested the previous generation of ANYmal (B) in a broad range of environments over the last few years and gained a lot of insights. Based on our learnings, it became clear that we would have to re-design the robot to meet the requirements of industrial customers in terms of safety, quality, reliability, and lifetime. There were different prototype stages both for the new drives and for single robot assemblies. Apart from electrical tests, we thoroughly tested the thermal control and ingress protection of various subsystems like the depth cameras and actuators.
What can ANYmal C do that the previous version of ANYmal can’t?
ANYmal C was redesigned with a focus on performance increase regarding actuation (new drives), computational power (new hexacore Intel i7 PCs), locomotion and navigation skills, and autonomy (new depth cameras). The new robot additionally features a docking system for autonomous recharging and an inspection payload as an option. The design of ANYmal C is far more integrated than its predecessor, which increases both performance and reliability.
How much of ANYmal C’s development and design was driven by your experience with commercial or industry customers?
Tests (such as the offshore installation with TenneT) and discussions with industry customers were important to get the necessary design input in terms of performance, safety, quality, reliability, and lifetime. Most customers ask for very similar inspection tasks that can be performed with our standard inspection payload and the required software packages. Some are looking for a robot that can also solve some simple manipulation tasks like pushing a button. Overall, most use cases customers have in mind are realistic and achievable, but some are really tough for the robot, like climbing 50° stairs in hot environments of 50°C.
Can you describe how much autonomy you expect ANYmal C to have in industrial or commercial operations?
ANYmal C is primarily developed to perform autonomous routine inspections in industrial environments. This autonomy especially adds value for operations that are difficult to access, as human operation is extremely costly. The robot can naturally also be operated via a remote control and we are working on long-distance remote operation as well.
Do you expect that researchers will be interested in ANYmal C? What research applications could it be useful for?
ANYmal C has been designed to also address the needs of the research community. The robot comes with two powerful hexacore Intel i7 computers and can additionally be equipped with an NVIDIA Jetson Xavier graphics card for learning-based applications. Payload interfaces enable users to easily install and test new sensors. By joining our established ANYmal Research community, researchers get access to simulation tools and software APIs, which boosts their research in various areas like control, machine learning, and navigation.
[ ANYmal C ] Continue reading
#435575 How an AI Startup Designed a Drug ...
Discovering a new drug can take decades, billions of dollars, and untold man hours from some of the smartest people on the planet. Now a startup says it’s taken a significant step towards speeding the process up using AI.
The typical drug discovery process involves carrying out physical tests on enormous libraries of molecules, and even with the help of robotics it’s an arduous process. The idea of sidestepping this by using computers to virtually screen for promising candidates has been around for decades. But progress has been underwhelming, and it’s still not a major part of commercial pipelines.
Recent advances in deep learning, however, have reignited hopes for the field, and major pharma companies have started tying up with AI-powered drug discovery startups. And now Insilico Medicine has used AI to design a molecule that effectively targets a protein involved in fibrosis—the formation of excess fibrous tissue—in mice in just 46 days.
The platform the company has developed combines two of the hottest sub-fields of AI: the generative adversarial networks, or GANs, which power deepfakes, and reinforcement learning, which is at the heart of the most impressive game-playing AI advances of recent years.
In a paper in Nature Biotechnology, the company’s researchers describe how they trained their model on all the molecules already known to target this protein as well as many other active molecules from various datasets. The model was then used to generate 30,000 candidate molecules.
Unlike most previous efforts, they went a step further and selected the most promising molecules for testing in the lab. The 30,000 candidates were whittled down to just 6 using more conventional drug discovery approaches and were then synthesized in the lab. They were put through increasingly stringent tests, but the leading candidate was found to be effective at targeting the desired protein and behaved as one would hope a drug would.
The authors are clear that the results are just a proof-of-concept, which company CEO Alex Zhavoronkov told Wired stemmed from a challenge set by a pharma partner to design a drug as quickly as possible. But they say they were able to carry out the process faster than traditional methods for a fraction of the cost.
There are some caveats. For a start, the protein being targeted is already very well known and multiple effective drugs exist for it. That gave the company a wealth of data to train their model on, something that isn’t the case for many of the diseases where we urgently need new drugs.
The company’s platform also only targets the very initial stages of the drug discovery process. The authors concede in their paper that the molecules would still take considerable optimization in the lab before they’d be true contenders for clinical trials.
“And that is where you will start to begin to commence to spend the vast piles of money that you will eventually go through in trying to get a drug to market,” writes Derek Lowe in his blog In The Pipeline. The part of the discovery process that the platform tackles represents a tiny fraction of the total cost of drug development, he says.
Nonetheless, the research is a definite advance for virtual screening technology and an important marker of the potential of AI for designing new medicines. Zhavoronkov also told Wired that this research was done more than a year ago, and they’ve since adapted the platform to go after harder drug targets with less data.
And with big pharma companies desperate to slash their ballooning development costs and find treatments for a host of intractable diseases, they can use all the help they can get.
Image Credit: freestocks.org / Unsplash Continue reading